Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6706986rdf:typepubmed:Citationlld:pubmed
pubmed-article:6706986lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:6706986lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:6706986lifeskim:mentionsumls-concept:C0205054lld:lifeskim
pubmed-article:6706986lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:6706986lifeskim:mentionsumls-concept:C0003316lld:lifeskim
pubmed-article:6706986lifeskim:mentionsumls-concept:C0010798lld:lifeskim
pubmed-article:6706986lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:6706986pubmed:issue6lld:pubmed
pubmed-article:6706986pubmed:dateCreated1984-5-4lld:pubmed
pubmed-article:6706986pubmed:abstractTextSpleen cells from a BALB/cByJ mouse previously immunized with purified rat liver microsomal cytochrome P-450c were fused with myeloma cells (P3X63Ag8.653) and 10 hybridoma clones secreting antibody against cytochrome P-450c were selected for characterization. The monoclonal antibodies (C1-C10) were purified from mouse ascites fluid and nine were determined to be distinct immunoglobulins. C6 was an IgG2b, whereas the rest were of the IgG1 subclass. A competitive enzyme-linked immunoassay was used to show that the antibodies were directed against at least five spatially distinct epitopes on cytochrome P-450c. Additional evidence for the recognition of distinct epitopes was provided by Ouchterlony immunoprecipitation of cytochrome P-450c with mixtures of appropriate monoclonal antibodies. Differences in antibody reactivity provided evidence for a sixth overlapping epitope that was recognized by two antibodies (C4 and C6). Three monoclonal antibodies to the same epitope on cytochrome P-450c, (CD2, CD3, and CD5) cross-reacted strongly with cytochrome P-450d, another isozyme induced by 3-methylcholanthrene treatment of rats. The antibodies that did not cross-react with cytochrome P-450d contained kappa light chains, whereas the three cross-reacting antibodies contained lambda light chains. None of the monoclonal antibodies cross-reacted with purified cytochromes P-450a, P-450b, P-450e, P-450f, P-450g, or P-450h or any other cytochrome P-450 in "Western blots" of liver microsomes from untreated or 3-methylcholanthrene-treated rats. C8 was a potent inhibitor of metabolism catalyzed by cytochrome P-450c in a reconstituted system as well as microsomes from 3-methylcholanthrene-treated rats. This antibody effected maximal inhibition of catalytic activity at an approximately 0.5:1 molar ratio of IgG to cytochrome P-450c, i.e. one antibody-binding site per epitope on cytochrome P-450c.lld:pubmed
pubmed-article:6706986pubmed:languageenglld:pubmed
pubmed-article:6706986pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6706986pubmed:citationSubsetIMlld:pubmed
pubmed-article:6706986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6706986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6706986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6706986pubmed:statusMEDLINElld:pubmed
pubmed-article:6706986pubmed:monthMarlld:pubmed
pubmed-article:6706986pubmed:issn0021-9258lld:pubmed
pubmed-article:6706986pubmed:authorpubmed-author:LevinWWlld:pubmed
pubmed-article:6706986pubmed:authorpubmed-author:ThomasP EPElld:pubmed
pubmed-article:6706986pubmed:authorpubmed-author:RyanD EDElld:pubmed
pubmed-article:6706986pubmed:authorpubmed-author:ReikL MLMlld:pubmed
pubmed-article:6706986pubmed:issnTypePrintlld:pubmed
pubmed-article:6706986pubmed:day25lld:pubmed
pubmed-article:6706986pubmed:volume259lld:pubmed
pubmed-article:6706986pubmed:ownerNLMlld:pubmed
pubmed-article:6706986pubmed:authorsCompleteYlld:pubmed
pubmed-article:6706986pubmed:pagination3890-9lld:pubmed
pubmed-article:6706986pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:6706986pubmed:meshHeadingpubmed-meshheading:6706986-...lld:pubmed
pubmed-article:6706986pubmed:meshHeadingpubmed-meshheading:6706986-...lld:pubmed
pubmed-article:6706986pubmed:meshHeadingpubmed-meshheading:6706986-...lld:pubmed
pubmed-article:6706986pubmed:meshHeadingpubmed-meshheading:6706986-...lld:pubmed
pubmed-article:6706986pubmed:meshHeadingpubmed-meshheading:6706986-...lld:pubmed
pubmed-article:6706986pubmed:meshHeadingpubmed-meshheading:6706986-...lld:pubmed
pubmed-article:6706986pubmed:meshHeadingpubmed-meshheading:6706986-...lld:pubmed
pubmed-article:6706986pubmed:meshHeadingpubmed-meshheading:6706986-...lld:pubmed
pubmed-article:6706986pubmed:meshHeadingpubmed-meshheading:6706986-...lld:pubmed
pubmed-article:6706986pubmed:meshHeadingpubmed-meshheading:6706986-...lld:pubmed
pubmed-article:6706986pubmed:meshHeadingpubmed-meshheading:6706986-...lld:pubmed
pubmed-article:6706986pubmed:meshHeadingpubmed-meshheading:6706986-...lld:pubmed
pubmed-article:6706986pubmed:year1984lld:pubmed
pubmed-article:6706986pubmed:articleTitleCharacterization of nine monoclonal antibodies against rat hepatic cytochrome P-450c. Delineation of at least five spatially distinct epitopes.lld:pubmed
pubmed-article:6706986pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6706986lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6706986lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6706986lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6706986lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6706986lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6706986lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6706986lld:pubmed